(4S,5S)-(-)-2-甲基-5-苯基-2-恶唑啉-4-甲醇 | 53732-41-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: (4S,5S)-(-)-2-甲基-5-苯基-2-恶唑啉-4-甲醇
• 中文别名: (4S,5S)-(−)-2-甲基-5-苯基-噁唑啉-4-甲醇；(4S,5S)-(-)-2-甲基-5-苯基-2-噁唑啉-4-甲醇；(4S,5S)-(-)-2-甲基-5-苯基-2-唑啉-4-甲醇；(4S,5S)-(-)-4-羟甲基-2-甲基-5-苯基唑啉；(4S,5S)-(?)-2-甲基-5-苯基-噁唑啉-4-甲醇
• 英文名称: (+/-)-(2-methyl-5t-phenyl-4,5-dihydro-oxazol-4r-yl)-methanol
• 英文别名: (4S,5S)-(-)-2-Methyl-5-phenyl-2-oxazoline-4-methanol；[(4S,5S)-2-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-4-yl]methanol
• CAS: 53732-41-5
• 化学式: C₁₁H₁₃NO₂
• 分子量: 191.23
• InChiKey: NTCJMVHDZUBYNA-QWRGUYRKSA-N

物化性质

• 熔点：
  61-65 °C(lit.)
• 稳定性/保质期：
  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  41.8
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 安全说明：
  S22,S24/25
• 海关编码：
  2934999090

SDS

Name:	(4S 5S)-(-)-2-Methyl-5-Phenyl-2-Oxa-Zoline-4-Methanol Material Safety Data Sheet
Synonym:	None known
CAS:	53732-41-5

Section 1 - Chemical Product MSDS Name:(4S 5S)-(-)-2-Methyl-5-Phenyl-2-Oxa-Zoline-4-Methanol Material Safety Data Sheet
Synonym:None known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
53732-41-5	(4S,5S)-(-)-2-Methyl-5-Phenyl-2-Oxa-Zo	ca 100	258-730-2

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 53732-41-5: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: almost white
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C11H13NO2
Molecular Weight: 191.0965

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 53732-41-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(4S,5S)-(-)-2-Methyl-5-Phenyl-2-Oxa-Zoline-4-Methanol - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 53732-41-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 53732-41-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 53732-41-5 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (4S,5S)-(-)-2-甲基-5-苯基-2-恶唑啉-4-甲醇 在 sodium hydride 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 为溶剂， 生成 4-methoxymethyl-2-(2-methyl-pentyl)-5-phenyl-4,5-dihydro-oxazole
  参考文献：
  名称：

  Oxazolines. XXI. Kinetic resolution of sec-alkyl halides and simultaneous asymmetric synthesis of 3-alkylalkanoic acids using a chiral oxazoline. A method for determining absolute configurations and maximum optical rotations

  摘要：

  DOI：

  10.1021/ja00424a049
• 作为产物：
  描述：

  (2RS,3SR)-2-amino-3-hydroxy-3-phenyl-propionic acid ethyl ester 在 lithium aluminium tetrahydride 、 乙醚 、 氯仿 作用下， 生成 (4S,5S)-(-)-2-甲基-5-苯基-2-恶唑啉-4-甲醇
  参考文献：
  名称：

  DE830956

  摘要：

  公开号：
• 作为试剂：
  描述：

  diethylzinc 、 邻甲氧基苯甲醛 在 (4S,5S)-(-)-2-甲基-5-苯基-2-恶唑啉-4-甲醇 作用下， 以 正己烷 为溶剂， 生成 (R)-(+)-1-(2-methoxyphenyl)-1-propanol 、 (1S)-1-(2-甲氧基苯基)-1-丙醇
  参考文献：
  名称：

  Asymmetric addition of diethylzinc to aromatic aldehydes using enantiomerically pure hydroxymethyl oxazoline ligands

  摘要：

  The addition of diethylzinc to aromatic aldehydes in the presence of catalytic amounts of enantiomerically pure hydroxymethyl oxazolines affords the corresponding secondary alcohols with modest levels of asymmetric induction.

  DOI：

  10.1016/s0957-4166(00)80170-6

文献信息

• Diastereoselective conversion of sulfides into sulfoxides. 1,5- and 1,6-asymmetric induction
  作者：Justin F. Bower、Christopher J. Martin、David J. Rawson、Alexandra M. Z. Slawin、Jonathan M. J. Williams

  DOI：10.1039/p19960000333

  日期：——

  The diastereoselective oxidation of sulfides into sulfoxides has been achieved with enantiomerically pure dihydrooxazole auxiliaries. When an additional hydroxymethyl substituent is present, diastereocontrol is very high and 1,5-asymmetric induction has been achieved with up to 96 : 4 selectivity, and 1,6-asymmetric induction has been achieved with up to 97 : 3 selectivity in the absence of any additional chiral agents.

  用对映纯的二氢噁唑辅基实现了硫化物向亚磺酰胺的非对映选择性氧化。当存在额外的羟甲基取代基时，非对映选择性非常高，1,5-不对称诱导可达到96:4的选择性，而在没有额外的手性试剂的情况下，1,6-不对称诱导可达到97:3的选择性。
• Antagonists of melanin concentrating hormone effects on the melanin concetrating hormone receptor
  申请人：——

  公开号：US20030229119A1

  公开（公告）日：2003-12-11

  The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.

  本发明涉及通过黑素浓缩激素受体对黑素浓缩激素（MCH）效果的拮抗，对于预防或治疗进食障碍、体重增加、肥胖、生殖和性行为异常、甲状腺激素分泌、利尿和水/电解质平衡、感觉处理、记忆、睡眠、觉醒、焦虑、抑郁、癫痫发作、神经退行性疾病和精神疾病是有用的。
• Effect of Chain Length on Radical to Carbanion Cyclo-Coupling of Bromoaryl Alkyl-Linked Oxazolines:  1,3-Areneotropic Migration of Oxazolines
  作者：Laura J. Marshall、Mark D. Roydhouse、Alexandra M. Z. Slawin、John C. Walton

  DOI：10.1021/jo0620720

  日期：2007.2.1

  2-(1-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)-2-oxazoline, respectively. The major products from the precursor with a 5-C-atom spacer were derivatives of benzocycloheptane in which the oxazoline group had undergone a novel areneotropic migration from the end of the spacer to the benzo ring. The product from reaction of the corresponding 2-C-atom precursor was a 9-oxazolinophenanthrene derivative. EPR

  制备了具有2至6个C原子（n = 0-4）的烷基间隔基的2-卤苯基烷基-2-恶唑啉，其S RN考察了几种基本系统的1型反应。促进与相应的苯并环烷烃衍生物进行环偶联的最佳条件涉及在THF中使用LDA。具有3-C原子和4-C原子间隔基的前体可得到2-（1'-苯基茚满-1'-基）-2-恶唑啉和2-（1-苯基-1,2,3，分别为4-四氢萘-1-基）-2-恶唑啉。具有5-C原子间隔基的前体的主要产物是苯并环庚烷的衍生物，其中恶唑啉基团从间隔基的末端到苯并环经历了新的各向异性吸附。相应的2-C原子前体的反应产物是9-恶唑啉代菲衍生物。EPR光谱表明，LDA促进反应的中间体是产物苯并环烷烃的自由基阴离子。这支持一个SRN 1型链机制涉及通过间隔基团连接到氮杂酸酯离子的芳基的初始产生。分子内自由基与碳负离子的偶联随后产生了闭环的苯并环烷烃自由基阴离子，该阴离子将电子转移到更多的前体上。用含有手性2-恶唑啉
• METHOD FOR SYNTHESIS OF HALOPYRIDYL-ACYCLOPENTANE DERIVATIVE AND INTERMEDIATE THEREOF
  申请人：——

  公开号：US20020010339A1

  公开（公告）日：2002-01-24

  The present invention relates to a method for synthesis of an optically active halopyridyl-azacyclo-pentane derivative and the intermediate thereof which comprises preparing an optically active allene-1,3-dicarboxylic acid ester derivative from an optically active acetonedicarboxylic acid ester derivative and then proceeding through a 7-azabicyclo[2.2.1]heptane derivative to obtain the objective product.

  本发明涉及一种合成光学活性卤代吡啶-氮杂环戊烷衍生物及其中间体的方法，包括从光学活性丙酮二羧酸酯衍生物制备光学活性联二烯-1,3-二羧酸酯衍生物，然后通过7-氮杂双环[2.2.1]庚烷衍生物进行反应，以获得目标产物。
• Methods and systems for selective fluorination of organic molecules
  申请人：Fasan Rudi

  公开号：US20090061471A1

  公开（公告）日：2009-03-05

  A method and system for selectively fluorinating organic molecules on a target site wherein the target site is activated and then fluorinated are shown together with a method and system for identifying a molecule having a biological activity.

  一种用于有选择性地在目标位点上对有机分子进行氟化的方法和系统被展示，其中目标位点被激活，然后进行氟化，同时还展示了一种用于鉴定具有生物活性的分子的方法和系统。

表征谱图